VUNO’s AI-Powered Cardiac Arrest Risk Management System Earns CE MDR and UKCA Certifications
Early Regulatory Approval Accelerates Expansion Plans in Europe and the Middle East SEOUL, South Korea, May 12, 2025 /PRNewswire/ -- VUNO, a leading South Korean medical AI company, announced today that its flagship AI-powered cardiac arrest risk management system VUNO Med®-DeepCARS®(DeepCARS) has received CE MDR (Medical Device Regulation) certification in the European Union, as well as the...
Give the Gift of Health This Mother’s Day with VARON Oxygen Solutions
NEW YORK, May 9, 2025 /PRNewswire/ -- As families prepare to honor the women who have given them everything, VARON Oxygen Concentrators is spotlighting a vital but often overlooked gift: the ability to breathe easier, live more fully, and regain independence. In celebration of Mother's Day, VARON is launching a series of heartfelt campaigns...
Sands China Signs MOU for Macao-Hengqin Collaboration in Big Health Tourism Industry
Promotes Macao-Hengqin integration of Big Health tourism industry by leveraging respective advantages to create opportunities MACAO, May 9, 2025 /PRNewswire/ -- Sands China Ltd. and Guangdong-Macau Traditional Chinese Medicine Technology Industrial Park Development Co. Ltd. (GMTCM) have joined hands to promote the integration of the Big Health tourism industry in Macao and Hengqin by leveraging the advantages of...
CARsgen Announces Preliminary Clinical Data for Allogeneic BCMA CAR-T CT0596, Demonstrating Favorable Safety and Efficacy
SHANGHAI, May 12, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces preliminary clinical data for CT0596, an allogeneic BCMA-targeted CAR-T developed using the THANK-u Plus™ platform. CT0596 is currently being evaluated in an early exploratory clinical study for relapsed/refractory multiple...
Major strategic engagement program to create greater awareness of fertility health issues in the APAC region
SINGAPORE, May 12, 2025 /PRNewswire/ -- The Asia Pacific Initiative on Reproduction (ASPIRE) – the peak body harnessing expertise in assisted conception throughout the region – will embark on a major public education and awareness program on fertility health. It is also working to broaden its patient advocacy role through closer engagement...
Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025
SHANGHAI, May 11, 2025 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven clinical-stage gene therapy company focused on developing unique and novel solutions for rare and severe diseases, today announced a late-breaking abstract presentation on SKG1108, its investigational optogenetic gene therapy for Retinitis Pigmentosa (RP), at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting (May 13–17, 2025, New Orleans, Louisiana)....
Minghui Pharmaceutical Announces Strategic Partnership and Licensing Agreement with Qilu Pharmaceutical to Develop B7-H3 ADC in Greater China
SHANGHAI, May 9, 2025 /PRNewswire/ -- Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced an exclusive licensing and collaboration agreement with Qilu Pharmaceutical ("Qilu") for the development, manufacturing, and commercialization of its B7-H3 ADC (MHB088C) in Greater China (including Mainland China, Hong Kong, Macau, and Taiwan). Under the agreement, Qilu will obtain exclusive rights to MHB088C in...
IASO Bio Receives Orphan Drug Designation from the Saudi Food and Drug Authority for Equecabtagene Autoleucel
SHANGHAI, NANJING, China and SAN FRANCISCO, May 9, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that its self-developed BCMA-targeted CAR-T cell therapy product, Equecabtagene Autoleucel (FUCASO), has been granted Orphan Drug Designation (ODD) by the Saudi Food and Drug Authority...
THANARA: A Microbiome-Based Skincare Innovation Featuring 4P-Biotics Technology by AL-DNA
BANGKOK, May 9, 2025 /PRNewswire/ -- A professor from Chulalongkorn University's Faculty of Science has developed a skincare formula using microbiome and 4P-biotics technology, resulting in a serum and sunscreen lotion under the brand THANARA. These products help balance the microbiome on facial skin, promoting a healthy, youthful, clear, and acne-free complexion. THANARA: A...
EASWE A10 & B10 Electric Wheelchair Empowers Seniors & Disabled Individuals – No More Limited Mobility
LOS ANGELES, May 8, 2025 /PRNewswire/ -- EASWE, a forward-thinking mobility solutions company, is proud to introduce its latest innovations: the A10 and B10 electric wheelchairs. These two models are purposefully engineered to help seniors and individuals with disabilities regain their independence, enjoy greater freedom of movement, and live life without limits. Designed for both performance and comfort, the...
